FEB 13, 2024
Fork in the Road: Deciding Which Uveitis Treatment is Best
By
Christopher R Henry, MD,
Ghazala A Datoo O'Keefe, MD,
Edmund Tsui, MD,
Nisha Acharya, MD,
Douglas A Jabs, MD, MBA,
Parisa Emami Naeini, MD,
Shilpa Kodati,
Arjun B Sood, MD
2024 Clinical Webinars
Comprehensive Ophthalmology, Diagnostic Testing, Endothelial Keratoplasty, Immunosuppression, Infectious Uveitis , Medical Therapy , Uveitis
In this webinar, Drs. Acharya, Emami, Henry, Jabs, Kodati, O'Keefe, Sood, and Tsui, provide case management centered cases centered around four of the latest uveitis-related clinical trials. Clinical trials include:
- PeriOcular vs. INTravitreal Corticosteroids for Uveitic Macular Edema (POINT)/Intravitreal Therapy for Uveitic Macular Edema Ranibizumab versus Methotrexate versus the Dexamethasone Implant (MERIT)
First-line
- Antimetabolites as Steroid-sparing Treatment (FAST)
- Multicenter Uveitis Steroid Treatment Trial (MUST)